CurrentBlue Cross Blue Shield - MassachusettsPolicy 084

Anterior Segment Optical Coherence Tomography (AS-OCT)

This policy governs coverage and prior authorization for optical coherence tomography imaging of the anterior eye segment for Blue Cross Blue Shield - Massachusetts commercial and Medicare products, describing investigational status and coding guidance where present.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyAnterior Segment Optical Coherence Tomography (AS-OCT)

Policy CodePolicy 084

Change TypeAnnual review — no material changes

Effective Date

Next Review Date

Key ActionObtain precertification/preauthorization when the procedure is performed inpatient; outpatient prior authorization varies by product.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

1CPT code listed as investigational for commercial members

Annualpolicy review frequency

Policy 084policy identifier

4reference chunks in window

Coverage Determinations

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage stance

Covered when ALL of the following are met:

General coverage stance: Anterior segment optical coherence tomography (AS-OCT) of the anterior eye segment is considered investigational for Commercial members; current evidence is insufficient to demonstrate that AS-OCT improves net health outcomes for screening for angle-closure glaucoma or for many anterior segment pathologies. Although AS-OCT may detect more narrow or closed angles than gonioscopy and has reported uses in presurgical evaluation and monitoring postsurgical complications, uncertainty about the clinical significance of additional cases detected and a lack of long-term outcome data mean the technology is not established as medically necessary.

Policy statements unchanged through multiple annual reviews

For Blue Cross Blue Shield - Massachusetts commercial products, scanning computerized ophthalmic imaging of the anterior eye segment, including anterior segment optical coherence tomography (AS-OCT), is designated as investigational and not covered. The policy notes that evidence is limited and does not demonstrate that AS-OCT improves net health outcomes for screening or routine evaluation of anterior segment conditions.

This investigational stance applies to Commercial Members (Managed Care HMO/POS, PPO, and Indemnity) and is based on systematic reviews, cohort studies, and case series that show AS-OCT can detect more narrow or closed angles than gonioscopy but lack sufficient follow-up and validation to establish clinical benefit.

No additional explicit coverage exclusions beyond the investigational designation for commercial products are specified in the identified policy excerpts. Administrative resources and policy terms of use are referenced for broader procedural and programmatic guidance.

The evidence is insufficient to conclude that AS-OCT improves net health outcomes for detection of angle-closure glaucoma. Although studies show AS-OCT may identify more eyes with narrow or closed angles than gonioscopy, uncertainty remains about the proportion of true-positive versus false-positive findings and whether identification by AS-OCT predicts higher risk of future primary angle-closure glaucoma or leads to better clinical outcomes.

Similarly, for anterior eye segment diseases and pathologies (for example, dry eye syndrome, tumors, uveitis, or infections), available data are limited to case series and do not demonstrate that AS-OCT leads to improved diagnostic accuracy that translates into better health outcomes.

Within the provided excerpts there are no explicit statements labeled 'not medically necessary.' The document instead frames use of AS-OCT as investigational for commercial members and summarizes limitations in the evidence base; administrative links and Medical Policy terms of use are referenced for additional policy processes.

Provider Requirements and Administrative Actions

Prior Authorization

Prior Authorization / Precertification

Prior authorization/precertification is required when services described in this policy are performed in an inpatient setting for all products. For outpatient procedures, prior authorization requirements vary by product and benefit plan; some commercial products (for example certain PPO and Indemnity plans) may not cover the outpatient service. Providers must verify member-specific benefits and prior authorization requirements before scheduling services.

Prior authorization required for inpatient services (all products).
Outpatient prior authorization: product-dependent — confirm eligibility and coverage; some Commercial PPO/Indemnity products may not cover outpatient service.
Providers should check member contract benefits and product-specific rules prior to service.

Documentation Required

Coding and Documentation

Report services using current, industry-standard procedure (CPT/HCPCS), revenue, and diagnosis (ICD-10) codes and include appropriate modifiers where applicable. Inclusion or exclusion of a code in policy text does not guarantee coverage or reimbursement — always verify member benefits at the time of service.

Use most up-to-date CPT/HCPCS and ICD-10 codes and appropriate modifiers.
The code lists in policy are informational and not exhaustive.

Note

Administrative Links and Additional Provider Actions

No specific prior authorization forms, CPT/HCPCS codes, or step-therapy requirements are specified within this section. For administrative guidance, provider resources, and detailed policy terms, refer to Blue Cross Blue Shield of Massachusetts Medical Policy terms and related guideline links.

Medical Policy Terms of Use — refer to the carrier site for full terms and provider responsibilities.
Managed Care Guidelines, Indemnity/PPO Guidelines, Clinical Exception Process, Medical Technology Assessment Guidelines — consult as applicable.
No step therapy requirements or explicit outpatient authorization triggers are specified in this section; verify via product-specific rules.

Definitions and Key Terms

OCT / AS-OCT — definition of optical coherence tomography and anterior segment OCT

TermOptical coherence tomography (OCT) / Anterior segment OCT (AS-OCT)

DefinitionA noninvasive, high-resolution imaging technique that uses interference of reflected light to construct cross-sectional images of ocular structures.

Key technical detailCreates images by measuring coherent interference between reflected and reference light beams using an interferometer; sectional resolution typically 6–25 µm, with ultrahigh-resolution OCT achieving ~1.3 µm.

Anterior-segment specificsAS-OCT devices use a ~1.3-µm wavelength light source to penetrate the sclera and produce high-resolution cross-sectional images of the anterior chamber angle and ciliary body; pigment blocks imaging behind the iris.

Angle-closure glaucoma — definition

TermAngle-closure glaucoma

DefinitionA form of glaucoma characterized by obstruction of aqueous humor drainage through the trabecular meshwork due to a narrow or closed anterior chamber (iridocorneal) angle, which predisposes to increased intraocular pressure.

Clinical implicationAssessment requires evaluation of anterior segment anatomy (particularly the anterior chamber angle); a narrow angle can impede aqueous outflow and increase risk of optic nerve damage.

Related assessmentComprehensive glaucoma evaluation includes anterior segment assessment plus optic nerve, retinal nerve fiber layer imaging, visual field testing, and intraocular pressure measurement.

AS-OCT, UBM — definitions referenced in studies

TermAnterior segment OCT (AS-OCT)

Definition/usageAn OCT modality used to image anterior chamber anatomy, angle structures, corneal layers, and ciliary body; referenced in multiple studies for detecting narrow/closed angles, pre- and postoperative assessment, graft detachment, tumors, and surgical planning.

Ultrasound biomicroscopy (UBM)A high-frequency ultrasound technique for imaging anterior segment structures; used in comparative studies with AS-OCT for evaluation of anterior chamber dimensions and anterior segment tumors.

Comparative noteAS-OCT and UBM are both cited in the literature for assessment of angle closure and anterior segment pathology; choice of modality may depend on the specific structure imaged (eg, UBM can image behind pigmented iris areas that block AS-OCT).

OpenPayer

Anterior Segment Optical Coherence Tomography (AS-OCT)

Coverage Determinations

Coding Guidance

Provider Requirements and Administrative Actions

Background

Definitions and Key Terms